1,983
|
15556 |
Valsartan
|
|
decreases_activity of
|
AGTR1
|
|
|
15037562
|
Diabetes mellitus, type II
Insulin resistance
|
1,987
|
15595 |
fat cell differentiation
|
|
increases_expression of
|
AGTR1
|
in adipose tissue
|
15601 |
Irbesartan
|
|
decreases_activity of
|
AGTR1
|
in adipose tissue
|
|
12031955
|
Diabetes mellitus, type II
Insulin resistance
|
1,988
|
15613 |
Glucose
|
|
increases_expression of
|
AGTR1
|
in pancreas, in pancreatic islets
|
15618 |
Zofenopril
|
NOT |
increases_expression of
|
AGTR1
|
in pancreas, in pancreatic islets; after glucose stimulation
|
15621 |
Enalaprilat
|
NOT |
increases_expression of
|
AGTR1
|
in pancreas, in pancreatic islets; after glucose stimulation
|
|
16452552
|
Diabetes mellitus, type II
Insulin resistance
|
1,989
|
15682 |
Angiotensin II type 1 receptor blocker
|
|
decreases_activity of
|
AGTR1
|
|
|
20809236
|
Diabetes mellitus, type II
Stroke, ischemic
Myocardial infarction
Insulin resistance
Cardiovascular disease
Nephropathy, diabetic
Retinopathy, diabetic
Neuropathy, diabetic
|
1,997
|
15770 |
Telmisartan
|
|
decreases_activity of
|
AGTR1
|
|
|
20390403
|
Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
|
1,999
|
15824 |
Valsartan
|
|
decreases_expression of
|
AGTR1
|
in adipose tissue; after high-fat diet
|
|
20100990
|
Diabetes mellitus, type II
Insulin resistance
|
2,002
|
15887 |
Losartan
|
|
decreases_activity of
|
AGTR1
|
|
|
20808802
|
Diabetes mellitus, type II
Insulin resistance
|
2,018
|
15991 |
Losartan
|
|
decreases_activity of
|
AGTR1
|
|
46088 |
AGTR1
|
|
is_expressed_in
|
adipose tissue
|
|
|
15705782
|
Diabetes mellitus, type II
Insulin resistance
|
2,020
|
16004 |
hypertension
|
|
increases_expression of
|
AGTR1
|
in adipose tissue; in obese probands
|
16005 |
Cortisol
|
|
increases_expression of
|
AGTR1
|
in adipose tissue
|
16013 |
Insulin
|
NOT |
affects_expression of
|
AGTR1
|
in adipose tissue
|
16018 |
Estradiol
|
NOT |
affects_expression of
|
AGTR1
|
in adipose tissue
|
16023 |
Triiodothyronine
|
NOT |
affects_expression of
|
AGTR1
|
in adipose tissue
|
16028 |
Angiotensin II
|
NOT |
affects_expression of
|
AGTR1
|
in adipose tissue
|
|
12011658
|
Diabetes mellitus, type II
Obesity
Insulin resistance
|
2,039
|
16269 |
AGTR1
|
NOT |
affects_quantity of
|
mitochondrion
|
|
16271 |
AGTR1
|
|
affects_quantity of
|
Reactive oxygen species
|
in mitochondria
|
16273 |
AGTR1
|
|
affects_activity of
|
regulation of mitochondrial membrane potential
|
|
16283 |
AGTR1
|
|
affects_quantity of
|
Triacylglycerol
|
in skeletal muscle
|
16288 |
AGTR1
|
NOT |
affects_expression of
|
PPARGC1A
|
|
16290 |
AGTR1
|
NOT |
affects_expression of
|
TFAM
|
|
16296 |
AGTR1
|
|
affects_quantity of
|
Mitochondrial respiratory chain complex V
|
in mitochondria
|
16297 |
AGTR1
|
|
affects_quantity of
|
Mitochondrial respiratory chain complex IV
|
in mitochondria
|
16298 |
AGTR1
|
|
affects_expression of
|
ACADM
|
in mitochondria
|
|
19074984
|
Diabetes mellitus, type II
Insulin resistance
|
2,046
|
16338 |
Valsartan
|
|
decreases_activity of
|
AGTR1
|
|
|
18787107
|
Diabetes mellitus, type II
Insulin resistance
|
2,122
|
17389 |
HDL
|
|
decreases_expression of
|
AGTR1
|
in aorta
|
17399 |
hyperglycemia
|
|
increases_expression of
|
AGTR1
|
in aorta
|
17400 |
HDL
|
|
decreases_expression of
|
AGTR1
|
in aorta; if induced by hyperglycemia
|
|
19273745
|
Diabetes mellitus, type II
Insulin resistance
|
2,129
|
17500 |
obese Zucker rat
|
|
increases_quantity of
|
AGTR1
|
|
17508 |
Nebivolol
|
|
decreases_quantity of
|
AGTR1
|
in obese Zucker rats
|
|
21177830
|
Diabetes mellitus, type II
Insulin resistance
|
6,600
|
63216 |
Metformin
|
|
decreases_expression of
|
AGTR1
|
in the aorta
|
|
25527624
|
Diabetes mellitus, type II
Insulin resistance
|
7,511
|
74119 |
AHR
|
|
affects_expression of
|
AGTR1
|
|
|
20878756
|
Diabetes mellitus, type II
Insulin resistance
Inflammatory bowel disease
|
7,665
|
76781 |
mir-155
|
|
decreases_expression of
|
AGTR1
|
|
|
26550492
|
Gestational diabetes mellitus
|
8,191
|
82501 |
Angiotensin II
|
|
increases_activity of
|
AGTR1
|
|
82503 |
AGTR1
|
|
increases_activity of
|
Protein kinase C
|
|
|
26043887
|
Diabetes mellitus, type II
Insulin resistance
Nephropathy, diabetic
|
9,551
|
101279 |
VAV2
|
|
affects_expression of
|
AGTR1
|
|
|
17202406
|
Cardiovascular disease
|
11,709
|
116209 |
ACE inhibitor
|
|
decreases_activity of
|
AGTR1
|
|
116224 |
Angiotensin II type 1 receptor blocker
|
|
decreases_activity of
|
AGTR1
|
|
|
29598869
|
Cardiovascular disease
|
11,717
|
116305 |
Obesity
|
|
increases_expression of
|
AGTR1
|
in pancreas
|
116324 |
AGTR1
|
|
is_expressed_in
|
pancreatic islet
|
|
116333 |
Insulin resistance
|
|
increases_expression of
|
AGTR1
|
in pancreas
|
116335 |
AGTR1
|
|
decreases_activity of
|
proinsulin synthesis
|
in pancreas
|
116341 |
AGTR1
|
|
increases_activity of
|
response to oxidative stress
|
in pancreas
|
116343 |
AGTR1
|
|
increases_activity of
|
apoptotic process
|
in pancreas
|
116345 |
AGTR1
|
|
increases_activity of
|
pancreas fibrosis
|
|
116395 |
ACE2
|
|
affects_expression of
|
AGTR1
|
in pancreas
|
116409 |
Angiotensin II
|
|
increases_activity of
|
AGTR1
|
|
116410 |
AGTR1
|
|
increases_activity of
|
vasoconstriction
|
|
116411 |
AGTR1
|
|
increases_activity of
|
inflammatory response
|
|
116412 |
AGTR1
|
|
increases_activity of
|
pancreas fibrosis
|
|
116413 |
AGTR1
|
|
increases_activity of
|
response to oxidative stress
|
|
116416 |
AGTR1
|
|
affects_activity of
|
insulin secretion involved in cellular response to glucose stimulus
|
|
116417 |
AGTR1
|
|
affects_activity of
|
glucagon secretion
|
|
116418 |
AGTR1
|
|
affects_expression of
|
IRS1
|
in pancreatic islets
|
116419 |
AGTR1
|
|
affects_expression of
|
IRS2
|
in pancreatic islets
|
116420 |
AGTR1
|
|
affects_expression of
|
Phosphatidylinositol 3-kinase
|
in pancreatic islets
|
116421 |
AGTR1
|
|
affects_expression of
|
AKT2
|
in pancreatic islets
|
116422 |
AGTR1
|
|
affects_activity of
|
SLC2A2
|
in pancreatic islets
|
116423 |
AGTR1
|
|
affects_activity of
|
GCK
|
in pancreatic islets
|
116424 |
AGTR1
|
|
increases_expression of
|
IL1B
|
in pancreatic islets
|
116425 |
AGTR1
|
|
increases_activity of
|
NF-kappaB complex
|
in pancreatic islets
|
116426 |
AGTR1
|
|
increases_expression of
|
NOS2
|
in pancreatic islets
|
116427 |
Valsartan
|
|
decreases_activity of
|
AGTR1
|
|
116433 |
TNFRSF11B
|
|
increases_expression of
|
AGTR1
|
|
|
30404071
|
Diabetes mellitus, type II
Insulin resistance
|
11,748
|
116371 |
Angiotensin II
|
|
increases_activity of
|
AGTR1
|
|
116372 |
Angiotensin IV
|
|
increases_activity of
|
AGTR1
|
|
|
32333398
|
COVID-19
|
11,757
|
116446 |
AGTR1
|
|
increases_activity of
|
apoptotic process
|
in alveolar epithelial cell-derived carcinoma cell line A549
|
|
11880296
|
COVID-19
|
11,776
|
116578 |
Angiotensin II
|
|
increases_activity of
|
AGTR1
|
|
|
23463883
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
11,821
|
116760 |
MAS1
|
|
decreases_activity of
|
AGTR1
|
|
|
32341442
|
COVID-19
|
11,830
|
116887 |
AGTR1
|
|
affects_activity of
|
lung failure
|
in SARS-CoV S protein-treated mice
|
116888 |
AGTR1
|
|
affects_activity of
|
pulmonary edema
|
in SARS-CoV S protein-treated mice
|
|
16007097
|
SARS-CoV infection
|
11,899
|
117239 |
AGTR1
|
|
increases_activity of
|
ADAM17
|
in cerebrospinal fluid; during the development of DOCA-salt hypertension
|
|
28512108
|
Neurological
SARS-CoV infection
|
11,902
|
117160 |
AGTR1
|
|
increases_activity of
|
ADAM17
|
in the hypothalamus ; during DOCA-salt hypertension
|
|
28512108
|
Neurological
|
11,920
|
117253 |
Angiotensin A
|
|
increases_activity of
|
AGTR1
|
|
|
17138938
|
Cardiovascular disease
|
11,924
|
117260 |
AGTR1
|
|
increases_activity of
|
ADAM17
|
in myocardium
|
|
24332999
|
Endocrine
|
11,933
|
117309 |
Angiotensin II
|
|
interacts (colocalizes) with
|
AGTR1
|
in HEK293 cells
|
117310 |
Angiotensin III
|
|
interacts (colocalizes) with
|
AGTR1
|
in HEK293 cells
|
117311 |
Candesartan
|
|
interacts (colocalizes) with
|
AGTR1
|
in HEK293 cells
|
|
21542804
|
Cardiovascular disease
|